Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
November 3rd, 2023
Aroa Biosurgery – On track for Revenue of NZ$72 - NZ$75 Million
Read More
November 3rd, 2023
Neuren Pharmaceuticals – Strong DAYBUE Sales in September Quarter at US$67 million
Read More
October 10th, 2023
Acquisition Targets for Australian Biotech Sector (Cogstate)
Read More
October 10th, 2023
Major Validation Deal for Dimerix
Read More
October 3rd, 2023
Acquisition Targets for Australian Biotech Sector (Anteris Technologies)
Read More
October 3rd, 2023
Pharmaxis (Syntara) Sells off Mannitol Business
Read More
September 19th, 2023
Clinuvel Pharmaceuticals v. Nanosonics
Read More
September 19th, 2023
Polynovo v AROA Biosurgery
Read More
September 4th, 2023
Respiri Signs Three US Remote Patient Monitoring Contracts
Read More
September 4th, 2023
Disappointing Half Year Sales for Cogstate; Pipeline for New Contracts at All-time High Levels
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
